A nomogram for predicting distant brain failure in patients treated with gamma knife stereotactic radiosurgery without whole brain radiotherapy

Neuro-Oncology

Volumn 16, Issue 9, 2014, Pages 1283-1288

  Ayala Peacock, Diandra N ^a   Peiffer, Ann M ^a   Lucas, John T ^a   Isom, Scott ^a   Kuremsky, J Griff ^a   Urbanic, James J ^a   Bourland, J Daniel ^a   Laxton, Adrian W ^a   Tatter, Stephen B ^a   Shaw, Edward G ^a   Chan, Michael D ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Brain metastases; Distant brain failure; Nomogram; Stereotactic radiosurgery

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN DYSFUNCTION; BRAIN METASTASIS; BREAST CANCER; CANCER RADIOTHERAPY; DISEASE COURSE; DISTANT BRAIN FAILURE; FEMALE; FOLLOW UP; GAMMA KNIFE; GAMMA KNIFE RADIOSURGERY; HISTOPATHOLOGY; HUMAN; KIDNEY CARCINOMA; LUNG ADENOCARCINOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; NOMOGRAM; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTION; SALVAGE THERAPY; SQUAMOUS CELL CARCINOMA; SYSTEMIC DISEASE; WHOLE BRAIN RADIOTHERAPY; BRAIN NEOPLASMS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; RADIOSURGERY; SECONDARY; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NOMOGRAMS; RADIOSURGERY; TREATMENT OUTCOME;

EID: 84907006569     PISSN: 15228517     EISSN: 15235866     Source Type: Journal    
DOI: 10.1093/neuonc/nou018     Document Type: Article

References (18)

1. Niwinska A, Murawska M, Pogoda K. Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT). Ann Oncol. 21(5):942-948.
2. Jensen CA, Chan MD, McCoy TP, et al. Cavity-directed radiosurgery as adjuvant therapy after resection of a brain metastasis. J Neurosurg. 2011;114(6):1585-1591.
3. Lin NU, Dieras V, Paul D, et al. Multicenter phase II study of lapatinib in patients with brain metastases from HER2-positive breast cancer. Clin Cancer Res. 2009;15(4):1452-1459.
4. Nieder C, Leicht A, Motaref B, Nestle U, Niewald M, Schnabel K. Late radiation toxicity after whole brain radiotherapy: the influence of antiepileptic drugs. Am J Clin Oncol. 1999;22(6):573-579. (Pubitemid 30266055)
5. Sperduto PW, Chao ST, Sneed PK, et al. Diagnosis-specific prognostic factors, indexes, and treatment outcomes for patients with newly diagnosed brain metastases: a multi-institutional analysis of 4,259 patients. Int J Radiat Oncol Biol Phys. 2010;77(3):655-661.
6. Gaspar LE, Scott C, Murray K, Curran W. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. Int J Radiat Oncol Biol Phys. 2000;47(4):1001-1006. (Pubitemid 30345599)
7. Sawrie SM, Guthrie BL, Spencer SA, et al. Predictors of distant brain recurrence for patients with newly diagnosed brain metastases treated with stereotactic radiosurgery alone. Int J Radiat Oncol Biol Phys. 2008;70(1):181-186. (Pubitemid 350251044)
8. Griff Kuremsky J, Urbanic JJ, Jeff Petty W, et al. Tumor Histology Predicts Patterns of Failure and Survival in Patients with Brain Metastases from Lung Cancer Treated with Gamma Knife Radiosurgery. Neurosurgery. 2013;73(4):641-647.
9. Vern-Gross TZ, Lawrence JA, Case LD, et al. Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery. J Neurooncol. 2012;110(3):381-388.
10. Lester SC, Taksler GB, Kuremsky JG, et al. Clinical and economic outcomes of patients with brain metastases based on symptoms. Cancer. 2014;120(3):433-41.
11. Shaw E, Scott C, Souhami L, et al. Single dose radiosurgical treatment of recurrent previously irradiated primary brain tumors and brain metastases: final report of RTOG protocol 90-05. Int J Radiat Oncol Biol Phys. 2000;47(2):291-298. (Pubitemid 30236367)
12. Harrell FE Jr. Regression Modeling Strategies "rms" package version 3.6-3. 2013.
13. Aoyama H, Shirato H, Tago M, et al. Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial. JAMA. 2006;295(21):2483- 2491. (Pubitemid 43854963)
14. Soffietti R, Kocher M, Abacioglu UM, et al. A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol. 2013;31(1):65-72.
15. Chang EL, Wefel JS, Hess KR, et al. Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol. 2009;10(11):1037-1044.
16. Regine WF, Huhn JL, Patchell RA, et al. Risk of symptomatic brain tumor recurrence and neurologic deficit after radiosurgery alone in patients with newly diagnosed brain metastases: results and implications. Int J Radiat Oncol Biol Phys. 2002;52(2):333-338. (Pubitemid 34172998)
17. Patel TR, Ozturk AK, Knisely JP, Chiang VL. Implications of Identifying Additional Cerebral Metastases during Gamma Knife Radiosurgery. Int J Surg Oncol. 2012;2012:748284.
18. Kress MA, Oermann E, Ewend MG, Hoffman RB, Chaudhry H, Collins B. Stereotactic radiosurgery for single brain metastases from non-small cell lung cancer: progression of extracranial disease correlates with distant intracranial failure. Radiat Oncol. 2013;8:64.